|
|
|
Quick Links
NCRR and the 2009 Recovery Act
|
Upcoming EventsMeetings of interest to NCRR grantees and the biomedical research community. SEE ALSO: CTSA Pharmaceutical Assets Portal: Matching Academia and Industry for Drug RepositioningDecember 4 Drug repositioning, or finding new uses for drugs originally designed for another purpose, has become more important recently as many pharmaceutical companies are seeing their drug pipelines dry up. With the high cost of drug research and development, drug repositioning offers a way to explore these previously shelved assets. The Clinical and Translational Science Award (CTSA) Pharmaceutical Assets Portal is a tool that aims to match researchers’ scientific knowledge of targets and diseases with the repositioning needs of the pharmaceutical industry to potentially increase the number of approved drugs for alternative uses. Join your colleagues for a half-day conference that will bring together leaders in the pharmaceutical industry, government, and research to explore current drug repositioning efforts. Registration is requested by November 25, 2009. REGISTER NOW ADDITIONAL INFORMATION AND LOGISTICS 144th Meeting of the National Advisory Research Resources CouncilJanuary 26 The National Advisory Research Resources Council comprises 18 appointed members who serve for overlapping four-year terms. The membership includes leaders in scientific disciplines related to the activities of NCRR, as well as members of the general public who are leaders in fields of public and health policies, law, economics and management. The Council meets three times a year to conduct second-level review of applications as required by law. The Council also advises NCRR on other funding activities, policies and program considerations. |
| National Institutes of Health (NIH) Bethesda, Maryland 20892 |
Department of Health and Human Services |